Sponsor:
M.D. Anderson Cancer Center
Code:
NCT07382583
Conditions
Levonorgestrel
Intrauterine Systems
Prevention
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Survey using a questionnaire
Brief summary:
Conditions
Levonorgestrel
Intrauterine Systems
Prevention
Endometrial Cancer
Study ID
NCT07382583
Start date
Feb 12, 2026
Status verified date
Feb, 2026
Completion date
Feb 1, 2030
Anticipated
Primary completion date
Feb 1, 2028
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
270 participants
Anticipated
Arms
Phase 1
Phase 2
Interventions
Survey using a questionnaire
Primary outcome measure
Central contacts
Locations
The Harris Health System (LBJ)
Recruiting
Houston, Texas, United States, 77026
Contacts
Principal Investigator:
Larissa Meyer, MD
MD Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Larissa A Meyer, MD
Sponsor
M.D. Anderson Cancer Center
Last update posted
Aug 12, 2026
Last verified
Feb, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-08-12.